Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region

被引：0
作者：
Vikas P Chaubey
Johann D D Pitout
Bruce Dalton
Daniel B Gregson
Terry Ross
Kevin B Laupland
机构：
[1] University of Calgary,Department of Community Health Sciences
[2] Administration Office,Department of Medicine
[3] Foothills Medical Centre - North Tower,Department of Pathology and Laboratory Medicine
[4] University of Calgary,Department of Microbiology, Immunology and Infectious Diseases
[5] University of Calgary,Centre for Antimicrobial Resistance
[6] Health Research Innovation Centre,Department of Pharmacy Services
[7] University of Calgary,undefined
[8] Calgary Laboratory Services,undefined
[9] Alberta Health Services,undefined
[10] University of Calgary,undefined
[11] Alberta Health Services,undefined
[12] Foothills Medical Centre,undefined
[13] FRCPC,undefined
[14] MDCM,undefined
来源：
BMC Infectious Diseases | / 14卷
关键词：
Beta-lactamases; Bacteremia; Enterobacteriaceae;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 234 条
[1]  
Jacoby GA(2005)The new beta-lactamases N Engl J Med 352 380-391
[2]  
Munoz-Price LS(2002)Plasmid-determined AmpC-type beta-lactamases Antimicrob Agents Chemother 46 1-11
[3]  
Philippon A(2005)Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals Antimicrob Agents Chemother 49 358-365
[4]  
Arlet G(2002)Cephalosporinase induction and cephalosporin resistance: a longstanding misinterpretation Clin Microbiol Infect 8 823-825
[5]  
Jacoby GA(2009)AmpC beta-lactamases Clinical microbiology reviews 22 161-182
[6]  
Mulvey MR(2004)Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae? Clin Microbiol Infect 10 84-85
[7]  
Bryce E(1988)Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins Rev Infect Dis 10 830-838
[8]  
Boyd DA(2006)Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 34 1589-1596
[9]  
Ofner-Agostini M(1991)Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy Ann Intern Med 115 585-590
[10]  
Land AM(2001)Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp Antimicrob Agents Chemother 45 2628-2630
12345678910